Alternative Treatment For Bipolar II Depression: Psilocybin Safe And Effective, AMA Study Finds - Compass Pathways (NASDAQ:CMPS)

A COMPASS Pathways (NASDAQ: CMPS)-backed clinical trial assessing psilocybin-assisted psychotherapy for bipolar II disorder has provi

Related Keywords

United States ,American ,Natalie Gukasyan ,Scott Aaronson ,Sandeep Nayak ,Davidb Yaden ,Baltimore Sheppard Pratt ,Ben Adlin ,Johns Hopkins Centre For Psychedelic ,Sheppard Pratt Center ,Journal Of The American Medical Association ,Consciousness Research ,Psilocybin Research ,Marijuana Moment ,American Medical Association ,Sheppard Pratt Hospital ,Johns Hopkins Centre ,